BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fluoxetine
,
rs2230926
,
BRCA1
,
cell-cell adhesion
,
Inflammatory disorder
,
Prostate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
influenza H1N1
Summary
General Info
Curated Studies
Most Correlated Studies
Influenza H1N1 (A/WSN/33) infected embryonic fibroblasts 2, 4, 6 and 8hr post infection
Tracheobronchial epithelial cells infected with H3N2, attenuated H5N1, and H1N1 viruses
Primary monocytes infected with high or low pathogenicity influenza viruses
Macrophages infected with H1N1 and H5N1 strains of Influenza A
Blood from patients with fevers due to Rhinovirus, strains of influenza, or indeterminate cause
Explore Curated Studies Results
Literature
Most Relevant Literature
Naturally occurring PAE206K point mutation in 2009 H1N1 pandemic influenza viruses impairs viral rep…
Fatal Viral and Bacterial Septicemia in a Seventeen-Year-Old Woman with Immunodepressive Influenza A…
Carambolaside W Inhibited H1N1 Influenza Virus-Induced Oxidative Stress through STAT-3/BCL-XL Signal…
Molecular identification of neuraminidase gene mutations in influenza A/H1N1 and A/H3N2 isolates of …
Avian Influenza A(H5N1) Neuraminidase Inhibition Antibodies in Healthy Adults after Exposure to Infl…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Tomographic Findings in COVID-19 and Influenza H1N1
Antiviral Therapy for Influenza A H1N1
Novel Influenza A (H1N1) Surveillance Registry
Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months Infants
A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ